logo

For the Inventor, By the Inventor

Freising, Germany

Pieris Ag

Calculating rank
USPTO Granted Patents = 16

% Expired Patents = 25.0



Trademarks = 2

Forward Citations = 312

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Arne Skerra (12 out of 40 patents)

silverMedal Andreas Hohlbaum (8 out of 22 patents)

bronzeMedal Steffen Schlehuber (7 out of 10 patents)

4.  Gabriele Matschiner (6 out of 21 patents)

5.  Kristian Hobolt Jensen (4 out of 16 patents)

6.  Martin Huelsmeyer (4 out of 12 patents)

7.  Gerald Beste (4 out of 4 patents)

8.  Frank Schmidt (4 out of 6 patents)

9.  Thomas Stibora (4 out of 4 patents)

10.  Stefan Trentmann (3 out of 9 patents)

11.  Hans-Juergen Christian (2 out of 5 patents)

12.  Eric Boudreau (2 out of 8 patents)

13.  Richard Jones (2 out of 3 patents)

14.  Ian Kimber (2 out of 3 patents)

15.  Rebecca Dearman (2 out of 3 patents)


16 patents:

1. 9260492 - Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3) (2016-02-16),
2. 9221887 - Muteins of tear lipocalin and methods for obtaining the same (2015-12-29),
3. 9221885 - Muteins of human lipocalin 2 with affinity for CTLA-4 (2015-12-29),
4. 9212208 - Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same (2015-12-15),
5. 9051382 - Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such (2015-06-09),
6. 8986951 - Tear lipocalin in muteins binding IL-4 R alpha (2015-03-24),
7. 8536307 - Anticalins (2013-09-17),
8. 8313924 - Muteins of tear lipocalin and methods for obtaining the same (2012-11-20),
9. 8158753 - Anticalins (2012-04-17),
10. 7893208 - Muteins of human tear lipocalin (2011-02-22),
11. 7892827 - Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4) (2011-02-22),
12. 7723476 - Anticalins (2010-05-25),
13. 7691970 - Muteins of a bilin-binding protein with affinity for a given target (2010-04-06),
14. 7585940 - Muteins of human tear lipocalin (2009-09-08),
15. 7252998 - Muteins of human neutrophil gelatinase-associated lipocalin and related proteins (2007-08-07),
Company Overview
Pieris AG is a biotechnology company based in Freising, Germany, specializing in the development of innovative therapeutics using its proprietary Anticalin technology. This platform enables the design of proteins that can target specific disease pathways, particularly in the fields of oncology and respiratory diseases. Pieris focuses on advancing its pipeline of drug candidates through strategic partnerships and collaborations, aiming to address unmet medical needs with precision medicine solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

16 Patents

#4 in Freising

#2,626 in Germany

#37,887 in the World

Freising, DE
Freising, Germany

Pieris Ag

Forward Citations = 312

21 inventors:

goldMedal Arne Skerra (12 out of 40 patents)

silverMedal Andreas Hohlbaum (8 out of 22 patents)

bronzeMedal Steffen Schlehuber (7 out of 10 patents)

4.  Gabriele Matschiner (6 out of 21 patents)

5.  Kristian Hobolt Jensen (4 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pieris Ag. Retrieved from https://idiyas.com/company/pieris-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…